Literature DB >> 16904025

Efficacy of very high dose steroid treatment in a case of Landau-Kleffner syndrome.

Siobhan Gallagher1, Shelley Weiss, Janis Oram Cardy, Tom Humphries, Karen E Harman, Shay Menascu.   

Abstract

Landau-Kleffner syndrome (LKS) is an acquired childhood aphasia associated with paroxysmal bitemporal electroencephalogram (EEG) abnormalities and, sometimes, clinical seizures. We report the case of a female aged 5 years 6 months who presented clinically with apparent hearing loss, deterioration in speech, and seizure activity over 12 days. The female had previous detailed speech/language assessments at 3 to 4 years of age due to articulation delay. LKS was diagnosed on EEG with bitemporal spike and wave activity during sleep. The patient was treated with high dose prednisolone 3mg/kg/day, intensive speech/language therapy, and followed a modified educational program. We recorded a marked regression in receptive and expressive language skills, as well as her speech, language, and cognitive profiles before and during treatment with prednisolone, during an 18-month follow-up period. The patient demonstrated an excellent clinical response highlighting the importance of a multidisciplinary approach to management of LKS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904025     DOI: 10.1017/S0012162206001630

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  8 in total

Review 1.  "Electro-clinical syndromes" with onset in paediatric age: the highlights of the clinical-EEG, genetic and therapeutic advances.

Authors:  Pasquale Parisi; Alberto Verrotti; Maria Chiara Paolino; Rosa Castaldo; Filomena Ianniello; Alessandro Ferretti; Francesco Chiarelli; Maria Pia Villa
Journal:  Ital J Pediatr       Date:  2011-12-19       Impact factor: 2.638

2.  Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy.

Authors:  Maria Carmela Pera; Giovanna Randazzo; Silvia Masnada; Serena Donetti Dontin; Valentina De Giorgis; Umberto Balottin; Pierangelo Veggiotti
Journal:  Funct Neurol       Date:  2015 Jul-Sep

Review 3.  Current Treatment Options for Early-Onset Pediatric Epileptic Encephalopathies.

Authors:  Rolla Shbarou
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

4.  "Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings.

Authors:  Pasquale Parisi; Alberto Spalice; Francesco Nicita; Laura Papetti; Fabiana Ursitti; Alberto Verrotti; Paola Iannetti; Maria Pia Villa
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

5.  Epileptic encephalopathies in adults and childhood.

Authors:  Zekiye Kural; Ali Fahir Ozer
Journal:  Epilepsy Res Treat       Date:  2012-09-27

6.  Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.

Authors:  Richard E Frye; Swapna Sreenivasula; James B Adams
Journal:  BMC Pediatr       Date:  2011-05-18       Impact factor: 2.125

Review 7.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

8.  Clinical profile of patients with rolandic epilepsy at a clinic in rural Maharashtra.

Authors:  Sunil Sable; Rachna Sable; Parag Tamhankar; Vasundhara Tamhankar
Journal:  J Family Med Prim Care       Date:  2021-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.